Endovia Health Sciences (EDVA) Cost of Revenue (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Cost of Revenue (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.92 Bn | 133.07 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.02 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 57.31 Bn | 52.17 Bn | 52.00 Mn | 93.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | - |
| 6 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 174.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.51 Bn | 32.21 Bn | 992.69 Mn | 298.26 Mn |
| 8 | Royalty Pharma | 28.21 Bn | 27.37 Bn | - | - |
| 9 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 67.21 Mn |
| 10 | Endovia Health Sciences | 815,264.74 | 572,562.74 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,376.00 |
| Dec 31, 2025 | -412,547.00 |
| Sep 30, 2025 | 416,913.00 |
| Jun 30, 2025 | 8,740.00 |
| Mar 31, 2025 | 43,062.00 |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | 690,839.00 |
| Jun 30, 2024 | 802,352.00 |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 2.38 Mn |